Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan Ledermann

Showing results (1-10 of 45) with videos related to

Pageof 5
Sort By:
Therapeutic Advances in Medical Oncology|August 23, 2021
Immune checkpoint inhibitors in ovarian cancer: where do we stand?Alexandra Leary, David Tan, Jonathan Ledermann
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 1, 2025
Controversies in the organization and structure of management for rare tumorsIsabelle Ray-Coquard, Jonathan Ledermann, Anna DeFazio, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 23, 2023
Evaluating open access publication and research impact in gynecologic oncologyGabriel Levin, Ross Harrison, Jonathan Ledermann, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 27, 2015
Do Cell-Cycle Phase-Specific Markers Predict Disease Grade, Stage, and Outcome in Cervical Carcinoma?Stephanie Kuku, Ian Proctor, Marco Loddo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 21, 2019
Mainstreamed genetic testing in ovarian cancer: patient experience of the testing processLaura McLeavy, Belinda Rahman, Rebecca Kristeleit, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 6, 2011
2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus ConferenceGavin C E Stuart, Henry Kitchener, Monica Bacon, et al.
Critical Reviews in Oncology/Hematology|February 22, 2002
High-dose chemotherapy for solid tumors: results of the EBMTGiovanni Rosti, Patrizia Ferrante, Jonathan Ledermann, et al.
The Journal of Infectious Diseases|January 29, 2003
Herpes simplex virus infection of dendritic cells: balance among activation, inhibition, and immunityGabriele Pollara, Katharina Speidel, Laila Samady, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 17, 2023
An easy, fast, and accurate way for implementing the standards of care for the management of patients with endometrial carcinoma into daily clinical practice: the ESGO mobile appThomas Gaillard, Richard Schwameis, Enora Laas-Faron, et al.
Clinical Trials (London, England)|July 27, 2019
Impact of retrospective data verification to prepare the ICON6 trial for use in a marketing authorization applicationAndrew Embleton-Thirsk, Elizabeth Deane, Stephen Townsend, et al.
Pageof 5

Showing results (1-10 of 45) with videos related to

Sort By:
Pageof 5
Therapeutic Advances in Medical Oncology|August 23, 2021
Immune checkpoint inhibitors in ovarian cancer: where do we stand?Alexandra Leary, David Tan, Jonathan Ledermann
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 1, 2025
Controversies in the organization and structure of management for rare tumorsIsabelle Ray-Coquard, Jonathan Ledermann, Anna DeFazio, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 23, 2023
Evaluating open access publication and research impact in gynecologic oncologyGabriel Levin, Ross Harrison, Jonathan Ledermann, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|January 27, 2015
Do Cell-Cycle Phase-Specific Markers Predict Disease Grade, Stage, and Outcome in Cervical Carcinoma?Stephanie Kuku, Ian Proctor, Marco Loddo, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|November 21, 2019
Mainstreamed genetic testing in ovarian cancer: patient experience of the testing processLaura McLeavy, Belinda Rahman, Rebecca Kristeleit, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|May 6, 2011
2010 Gynecologic Cancer InterGroup (GCIG) consensus statement on clinical trials in ovarian cancer: report from the Fourth Ovarian Cancer Consensus ConferenceGavin C E Stuart, Henry Kitchener, Monica Bacon, et al.
Critical Reviews in Oncology/Hematology|February 22, 2002
High-dose chemotherapy for solid tumors: results of the EBMTGiovanni Rosti, Patrizia Ferrante, Jonathan Ledermann, et al.
The Journal of Infectious Diseases|January 29, 2003
Herpes simplex virus infection of dendritic cells: balance among activation, inhibition, and immunityGabriele Pollara, Katharina Speidel, Laila Samady, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|July 17, 2023
An easy, fast, and accurate way for implementing the standards of care for the management of patients with endometrial carcinoma into daily clinical practice: the ESGO mobile appThomas Gaillard, Richard Schwameis, Enora Laas-Faron, et al.
Clinical Trials (London, England)|July 27, 2019
Impact of retrospective data verification to prepare the ICON6 trial for use in a marketing authorization applicationAndrew Embleton-Thirsk, Elizabeth Deane, Stephen Townsend, et al.
Pageof 5